Title 21

PART 201 SUBPART C

Subpart C - Labeling Requirements for Over-the-Counter Drugs Source:41 FR 6908, Feb. 13, 1976, unless otherwise noted.

• 21 U.S.C. 321, 331, 351, 352, 353, 355, 358, 360, 360b, 360gg-360ss, 371, 374, 379e; 42 U.S.C. 216, 241, 262, 264.
• Source: 40 FR 13998, Mar. 27, 1975, unless otherwise noted.

21:4.0.1.1.2.3.1.1	SECTION 201.60	201.60 Principal display panel.
21:4.0.1.1.2.3.1.2	SECTION 201.61	201.61 Statement of identity.
21:4.0.1.1.2.3.1.3	SECTION 201.62	201.62 Declaration of net quantity of contents.
21:4.0.1.1.2.3.1.4	SECTION 201.63	201.63 Pregnancy/breast-feeding warning.
21:4.0.1.1.2.3.1.5	SECTION 201.64	201.64 Sodium labeling.
21:4.0.1.1.2.3.1.6	SECTION 201.66	201.66 Format and content requirements for over-the-counter (OTC) drug product labeling.
21:4.0.1.1.2.3.1.7	SECTION 201.70	201.70 Calcium labeling.
21:4.0.1.1.2.3.1.8	SECTION 201.71	201.71 Magnesium labeling.
21:4.0.1.1.2.3.1.9	SECTION 201.72	201.72 Potassium labeling.
21:4.0.1.1.2.3.1.10	SECTION 201.80	201.80 Specific requirements on content and format of labeling for human prescription drug and biological products; older drugs not described in § 201.56(b)(1).

---